tovorafenib
day one biopharmaceutical
['pivotal data', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'pivot,io,i', 'tovorafenib', '$tgtx', '$dawn']
 this dude from baml (need to find who he is) predicted tovorafenib pivotal data at asco23 to be underwhelming and risk to potential filing soon after . he sure must be disgruntled unpaid intern as 3rd in row he sucks ($tgtx $axsm bad predictions earlier) $dawn
Investor with bios & tech focus. Tweets are my opinions only and not investment advice. May have positions short or long term on stocks I tweet.